Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 2
1973 1
1974 1
1975 5
1976 12
1977 6
1978 9
1979 4
1980 12
1981 11
1982 10
1983 25
1984 19
1985 20
1986 14
1987 31
1988 22
1989 39
1990 28
1991 17
1992 41
1993 30
1994 31
1995 38
1996 26
1997 49
1998 52
1999 45
2000 41
2001 35
2002 59
2003 62
2004 59
2005 70
2006 64
2007 87
2008 89
2009 93
2010 100
2011 93
2012 100
2013 128
2014 149
2015 158
2016 171
2017 177
2018 220
2019 186
2020 241
2021 233
2022 188
2023 177
2024 98

Text availability

Article attribute

Article type

Publication date

Search Results

3,173 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Hypertrophic cardiomyopathy 3"
Page 1
Sudden Cardiac Death in Hypertrophic Cardiomyopathy.
Adamczak DM, Oko-Sarnowska Z. Adamczak DM, et al. Cardiol Rev. 2018 May/Jun;26(3):145-151. doi: 10.1097/CRD.0000000000000184. Cardiol Rev. 2018. PMID: 29621050 Review.
Hypertrophic cardiomyopathy (HCM) is a heart disease characterized by hypertrophy of the left ventricular myocardium and is most often caused by mutations in sarcomere genes. ...
Hypertrophic cardiomyopathy (HCM) is a heart disease characterized by hypertrophy of the left ventricular myocardium and is mo …
Hypertrophic Cardiomyopathy and Pregnancy: A Retrospective Analysis From a Tertiary Care Hospital.
Sikka P, Suri V, Chopra S, Aggarwal N, Saha SC, Bansal R, Vijayvergiya R, Bahl A. Sikka P, et al. Tex Heart Inst J. 2022 Sep 1;49(5):e207427. doi: 10.14503/THIJ-20-7427. Tex Heart Inst J. 2022. PMID: 36223225 Free PMC article. Review.
Pregnancy in women with hypertrophic cardiomyopathy is not well described. In this retrospective study, we analyzed data on pregnant women with hypertrophic cardiomyopathy who were under follow-up care in the cardiology department of a tertiary care ho …
Pregnancy in women with hypertrophic cardiomyopathy is not well described. In this retrospective study, we analyzed data on pr …
Hypokinetic hypertrophic cardiomyopathy: clinical phenotype, genetics, and prognosis.
Wasserstrum Y, Larrañaga-Moreira JM, Martinez-Veira C, Itelman E, Lotan D, Sabbag A, Kuperstein R, Peled Y, Freimark D, Barriales-Villa R, Arad M. Wasserstrum Y, et al. ESC Heart Fail. 2022 Aug;9(4):2301-2312. doi: 10.1002/ehf2.13914. Epub 2022 Apr 30. ESC Heart Fail. 2022. PMID: 35488723 Free PMC article.
AIMS: To describe the phenotype, genetics, and events associated with the development of hypertrophic cardiomyopathy (HCM) with reduced ventricular function (HCMr). ...Patients who developed HCMr in the course of the study had similar mortality but a higher rate of …
AIMS: To describe the phenotype, genetics, and events associated with the development of hypertrophic cardiomyopathy (HCM) wit …
Hypertrophic cardiomyopathy with latent obstruction: Clinical characteristics and surgical results.
Ji Q, Wang Y, Liu F, Yang Y, Xia L, Ding W, Lai H, Wang C. Ji Q, et al. J Cardiol. 2022 Jan;79(1):42-49. doi: 10.1016/j.jjcc.2021.09.002. Epub 2021 Sep 20. J Cardiol. 2022. PMID: 34551867 Free article.
RESULTS: Comparatively, patients with latent obstruction were younger (51.612.1 years vs. 57.211.6 years, p=0.003) and had higher prevalence of mitral subvalvular abnormalities (73.3% vs. 16.2%, p<0.001) and basal variant of hypertrophic cardiomyopathy (84 …
RESULTS: Comparatively, patients with latent obstruction were younger (51.612.1 years vs. 57.211.6 years, p=0.003) and had higher prevalence …
Hypertrophic obstructive cardiomyopathy: review of surgical treatment.
Price J, Clarke N, Turer A, Quintana E, Mestres C, Huffman L, Peltz M, Wait M, Ring WS, Jessen M, Bajona P. Price J, et al. Asian Cardiovasc Thorac Ann. 2017 Nov;25(9):594-607. doi: 10.1177/0218492317733111. Epub 2017 Sep 13. Asian Cardiovasc Thorac Ann. 2017. PMID: 28901158 Review.
Hypertrophic cardiomyopathy ranks among the most common congenital cardiac diseases, affecting up to 1 in 200 of the general population. ...Pharmacologic therapy is the first-line treatment, but when it fails, surgical myectomy or percutaneous ablation of the hyp …
Hypertrophic cardiomyopathy ranks among the most common congenital cardiac diseases, affecting up to 1 in 200 of the general p …
Galectin-3 as a novel biomarker in cats with hypertrophic cardiomyopathy.
Stack JP, Fries RC, Kruckman L, Kadotani S, Wallace G. Stack JP, et al. J Vet Cardiol. 2023 Aug;48:54-62. doi: 10.1016/j.jvc.2023.06.003. Epub 2023 Jun 27. J Vet Cardiol. 2023. PMID: 37480722
INTRODUCTION/OBJECTIVES: Galectin-3 (Gal-3) is a circulating biomarker of fibrosis. In humans, increased Gal-3 is predictive of myocardial fibrosis and adverse cardiac events. The aim of this study was to evaluate the potential for Gal-3 as a cardiac b …
INTRODUCTION/OBJECTIVES: Galectin-3 (Gal-3) is a circulating biomarker of fibrosis. In humans, increased Gal-3 is predi …
Sudden death related cardiomyopathies - Hypertrophic cardiomyopathy.
Goff ZD, Calkins H. Goff ZD, et al. Prog Cardiovasc Dis. 2019 May-Jun;62(3):212-216. doi: 10.1016/j.pcad.2019.04.001. Epub 2019 Apr 17. Prog Cardiovasc Dis. 2019. PMID: 31004609 Review.
Hypertrophic cardiomyopathy (HCM) is a form of inherited cardiomyopathy. ...
Hypertrophic cardiomyopathy (HCM) is a form of inherited cardiomyopathy. ...
Apical Aneurysms and Mid-Left Ventricular Obstruction in Hypertrophic Cardiomyopathy.
Sherrid MV, Bernard S, Tripathi N, Patel Y, Modi V, Axel L, Talebi S, Ghoshhajra BB, Sanborn DY, Saric M, Adlestein E, Alvarez IC, Xia Y, Swistel DG, Massera D, Fifer MA, Kim B. Sherrid MV, et al. JACC Cardiovasc Imaging. 2023 May;16(5):591-605. doi: 10.1016/j.jcmg.2022.11.013. Epub 2023 Jan 11. JACC Cardiovasc Imaging. 2023. PMID: 36681586 Free article.
BACKGROUND: Apical left ventricular (LV) aneurysms in hypertrophic cardiomyopathy (HCM) are associated with adverse outcomes. ...Patients with aneurysms had 22% greater SAX PM areas compared with those with elevated LV velocities but no aneurysms (median: 3.0 …
BACKGROUND: Apical left ventricular (LV) aneurysms in hypertrophic cardiomyopathy (HCM) are associated with adverse outcomes. …
Genetics of hypertrophic cardiomyopathy.
Konno T, Chang S, Seidman JG, Seidman CE. Konno T, et al. Curr Opin Cardiol. 2010 May;25(3):205-9. doi: 10.1097/HCO.0b013e3283375698. Curr Opin Cardiol. 2010. PMID: 20124998 Free PMC article. Review.
PURPOSE OF REVIEW: Hypertrophic cardiomyopathy (HCM), the most common inherited cardiac disorder, exhibits remarkable genetic and clinical heterogeneity. ...
PURPOSE OF REVIEW: Hypertrophic cardiomyopathy (HCM), the most common inherited cardiac disorder, exhibits remarkable genetic …
3,173 results